A type-II positive allosteric modulator of α7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats.

A type-II positive allosteric modulator of α7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats.
复制标题

DOI:
10.1371/journal.pone.0073581
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Uteshev VV
Uteshev VV
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Sun F;Jin K;Uteshev VV

文献摘要

参考文献

被引文献

相似文献

在缺乏临床有效的缺血性卒中治疗方法的情况下,迫切需要开发新的治疗概念和方法来预防继发于脑缺血的脑损伤。本研究检验了以下假设:在缺血性卒中动物模型中,在局灶性脑缺血发作后6小时给予PNU-120596(α7烟碱乙酰胆碱受体(nAChR)的II型正变构调节剂(PAM-II))可显著降低脑损伤和神经功能缺损。通过短暂(90分钟)大脑中动脉闭塞(MCAO)诱导局灶性脑缺血。然后将动物分成两组,并静脉内(i. v.)MCAO后6小时,给予1 mg/kg PNU-120596(给药组)或仅给予溶媒(未给药组)。在MCAO后24小时进行脑梗死体积测量和神经行为测试。PNU-120596显著减少脑梗死体积并改善神经功能,如Bederson、滚柱和阶梯行走试验结果所证明。这些结果预示PAMs-II作为内源性α7 nAChR依赖性胆碱能通路的有效募集剂和激活剂具有很高的治疗潜力,可减少脑缺血性卒中后的脑损伤并改善神经功能。
In the absence of clinically-efficacious therapies for ischemic stroke there is a critical need for development of new therapeutic concepts and approaches for prevention of brain injury secondary to cerebral ischemia. This study tests the hypothesis that administration of PNU-120596, a type-II positive allosteric modulator (PAM-II) of α7 nicotinic acetylcholine receptors (nAChRs), as long as 6 hours after the onset of focal cerebral ischemia significantly reduces brain injury and neurological deficits in an animal model of ischemic stroke. Focal cerebral ischemia was induced by a transient (90 min) middle cerebral artery occlusion (MCAO). Animals were then subdivided into two groups and injected intravenously (i.v.) 6 hours post-MCAO with either 1 mg/kg PNU-120596 (treated group) or vehicle only (untreated group). Measurements of cerebral infarct volumes and neurological behavioral tests were performed 24 hrs post-MCAO. PNU-120596 significantly reduced cerebral infarct volume and improved neurological function as evidenced by the results of Bederson, rolling cylinder and ladder rung walking tests. These results forecast a high therapeutic potential for PAMs-II as effective recruiters and activators of endogenous α7 nAChR-dependent cholinergic pathways to reduce brain injury and improve neurological function after cerebral ischemic stroke.
DOI: 10.1016/j.neuropharm.2012.10.019
发表时间: 2013-04
期刊: Neuropharmacology
影响因子: 4.7
作者:
Callahan PM;Hutchings EJ;Kille NJ;Chapman JM;Terry AV Jr
通讯作者: Terry AV Jr
DOI: 10.1523/jneurosci.2444-07.2007
发表时间: 2007-09-26
影响因子: 5.3
作者:
Bitner, Robert S.;Bunnelle, William H.;Gopalakrishnan, Murali
通讯作者: Gopalakrishnan, Murali
DOI: 10.1007/s12031-009-9236-1
发表时间: 2010-01-01
影响因子: 3.1
作者:
Akaike, Akinori;Takada-Takatori, Yuki;Izumi, Yasuhiko
通讯作者: Izumi, Yasuhiko
DOI: 10.1161/01.str.17.3.472
发表时间: 1986-05-01
期刊: STROKE
影响因子: 8.3
作者:
BEDERSON, JB;PITTS, LH;BARTKOWSKI, H
通讯作者: BARTKOWSKI, H
DOI: 10.1016/j.neuroscience.2006.12.036
发表时间: 2007-03-30
期刊: NEUROSCIENCE
影响因子: 3.3
作者:
Egea, J.;Rosa, A. O.;Garcia, A. G.
通讯作者: Garcia, A. G.